- Treatment Research,
- Prevention Research,
- Diagnostic Research,
- Screening Research,
- Quality of Life Research,
- Genetic studies,
- Epidemiological studies,
- Clinical Trials,
- Others
Clinical Research Services Market size was valued at USD 47.06 billion in 2022 and is poised to grow at a CAGR of 9.41% from 2024-2030. Clinical research is a branch of healthcare that studies whether a medical strategy, medicine, medical device, diagnostics and treatment regimes is safe and effective for human use. Clinical research may contribute to treatment, prevention, diagnosis or relieving certain symptoms of disease or condition. Clinical research is carried out with a pool of patients or people under study condition. Clinical research is a broad term which includes many research studies such as treatment, prevention, diagnostic, screening, genetic, epidemiological and clinical trial studies. Clinical research services market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations.
Clinical Research Services Market Key Developments:
- In June 2017, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.
- In May, 2017 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization.
- In April 2016, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.
Global Clinical Research Services Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
9.4%
Largest Market
North America
Fastest Growing Market
North America
Clinical Research Services Market Dynamics
Global clinical research services market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the clinical research services market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the clinical research services market.
North-America Got Significant Share of
Clinical Research Services Market Regional Analysis
Geographically clinical research services market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America market expected to be leading clinical research services market owing to factors such as favourable regulations, developed infrastructure, increase in research and development activities and availability of pool of patients. Europe market expected to grow at significant rate owing to increase in R&D activities by pharma and biotechnological companies and favourable regulatory environment and government policies. Asia Pacific market is expected to be fastest growing owing to developing regulatory policies, low cost of the research and availability of a large number of patients.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Clinical Research Services Market Segmentation
By Type of Service
By Disease Area
- Oncology,
- Central Nervous System Disorders,
- Cardio Vascular Disorders,
- Diabetes,
- Infectious Diseases,
- Others
By End User
- Pharmaceutical Companies,
- Biotechnological Companies,
- Research Organizations,
- Others
Frequently Asked Questions
The clinical research services market is projected to expand at a CAGR of 9.41% during the forecast period
Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China)
North America is the fastest-growing region for clinical research services market
| 1.Executive Summary |
| 2.Global Clinical Research Services Market Introduction |
| 2.1.Global Clinical Research Services Market - Taxonomy |
| 2.2.Global Clinical Research Services Market - Definitions |
| 2.2.1.Type of Service |
| 2.2.2.Disease Area |
| 2.2.3. End User |
| 2.2.4.Region |
| 3.Global Clinical Research Services Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Clinical Research Services Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Clinical Research Services Market By Type of Service, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Treatment Research, |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Prevention Research, |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Diagnostic Research, |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Screening Research, |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Quality of Life Research, |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Genetic studies, |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Epidemiological studies, |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Clinical Trials, |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Others |
| 5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 6.Global Clinical Research Services Market By Disease Area , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Oncology, |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Central Nervous System Disorders, |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cardio Vascular Disorders, |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Diabetes, |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Infectious Diseases, |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Clinical Research Services Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pharmaceutical Companies, |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Biotechnological Companies, |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Organizations, |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Clinical Research Services Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Clinical Research Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Treatment Research, |
| 9.1.2.Prevention Research, |
| 9.1.3.Diagnostic Research, |
| 9.1.4.Screening Research, |
| 9.1.5.Quality of Life Research, |
| 9.1.6.Genetic studies, |
| 9.1.7.Epidemiological studies, |
| 9.1.8.Clinical Trials, |
| 9.1.9.Others |
| 9.2. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oncology, |
| 9.2.2.Central Nervous System Disorders, |
| 9.2.3.Cardio Vascular Disorders, |
| 9.2.4.Diabetes, |
| 9.2.5.Infectious Diseases, |
| 9.2.6.Others |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical Companies, |
| 9.3.2.Biotechnological Companies, |
| 9.3.3.Research Organizations, |
| 9.3.4.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Clinical Research Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type of Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Treatment Research, |
| 10.1.2.Prevention Research, |
| 10.1.3.Diagnostic Research, |
| 10.1.4.Screening Research, |
| 10.1.5.Quality of Life Research, |
| 10.1.6.Genetic studies, |
| 10.1.7.Epidemiological studies, |
| 10.1.8.Clinical Trials, |
| 10.1.9.Others |
| 10.2. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oncology, |
| 10.2.2.Central Nervous System Disorders, |
| 10.2.3.Cardio Vascular Disorders, |
| 10.2.4.Diabetes, |
| 10.2.5.Infectious Diseases, |
| 10.2.6.Others |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical Companies, |
| 10.3.2.Biotechnological Companies, |
| 10.3.3.Research Organizations, |
| 10.3.4.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Clinical Research Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type of Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Treatment Research, |
| 11.1.2.Prevention Research, |
| 11.1.3.Diagnostic Research, |
| 11.1.4.Screening Research, |
| 11.1.5.Quality of Life Research, |
| 11.1.6.Genetic studies, |
| 11.1.7.Epidemiological studies, |
| 11.1.8.Clinical Trials, |
| 11.1.9.Others |
| 11.2. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oncology, |
| 11.2.2.Central Nervous System Disorders, |
| 11.2.3.Cardio Vascular Disorders, |
| 11.2.4.Diabetes, |
| 11.2.5.Infectious Diseases, |
| 11.2.6.Others |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical Companies, |
| 11.3.2.Biotechnological Companies, |
| 11.3.3.Research Organizations, |
| 11.3.4.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Clinical Research Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type of Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Treatment Research, |
| 12.1.2.Prevention Research, |
| 12.1.3.Diagnostic Research, |
| 12.1.4.Screening Research, |
| 12.1.5.Quality of Life Research, |
| 12.1.6.Genetic studies, |
| 12.1.7.Epidemiological studies, |
| 12.1.8.Clinical Trials, |
| 12.1.9.Others |
| 12.2. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oncology, |
| 12.2.2.Central Nervous System Disorders, |
| 12.2.3.Cardio Vascular Disorders, |
| 12.2.4.Diabetes, |
| 12.2.5.Infectious Diseases, |
| 12.2.6.Others |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical Companies, |
| 12.3.2.Biotechnological Companies, |
| 12.3.3.Research Organizations, |
| 12.3.4.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Clinical Research Services Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type of Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Treatment Research, |
| 13.1.2.Prevention Research, |
| 13.1.3.Diagnostic Research, |
| 13.1.4.Screening Research, |
| 13.1.5.Quality of Life Research, |
| 13.1.6.Genetic studies, |
| 13.1.7.Epidemiological studies, |
| 13.1.8.Clinical Trials, |
| 13.1.9.Others |
| 13.2. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oncology, |
| 13.2.2.Central Nervous System Disorders, |
| 13.2.3.Cardio Vascular Disorders, |
| 13.2.4.Diabetes, |
| 13.2.5.Infectious Diseases, |
| 13.2.6.Others |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical Companies, |
| 13.3.2.Biotechnological Companies, |
| 13.3.3.Research Organizations, |
| 13.3.4.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Laboratory Corporation Of America Holdings (U.S.) |
| 14.2.2.Quintiles Transnational Holdings Inc. (U.S.) |
| 14.2.3.PAREXEL International Corporation (U.S.) |
| 14.2.4.ICON Plc (Ireland) |
| 14.2.5.PRA Health Sciences, Inc. (U.S.) |
| 14.2.6.InVentiv Health Inc. (U.S.) |
| 14.2.7.Wuxi AppTec (Cayman) Inc. (China) |
| 14.2.8.Pharmaceutical Product Development, LLC (U.S.) |
| 14.2.9.INC Research Holdings Inc. (U.S.) |
| 14.2.10.Charles River Laboratories International Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Laboratory Corporation Of America Holdings (U.S.)
- Quintiles Transnational Holdings Inc. (U.S.)
- PAREXEL International Corporation (U.S.)
- ICON Plc (Ireland)
- PRA Health Sciences, Inc. (U.S.)
- InVentiv Health Inc. (U.S.)
- Wuxi AppTec (Cayman) Inc. (China)
- Pharmaceutical Product Development, LLC (U.S.)
- INC Research Holdings Inc. (U.S.)
- Charles River Laboratories International Inc. (U.S.)